TerminatedNot Applicable

Treating Depression in Patients With De Quervain's Tenosynovitis; An Integrated Web Based Skills Intervention

Stopped: Data difficult to collect due to the COVID-19 pandemic.

United States22 participantsStarted 2018-12-10

Plain-language summary

This study evaluates a Decision Aid to help patients with de Quervain's tenosynovitis decide how to treat their condition. For patients with symptoms of depression, half the participants will receive a psychological intervention (Toolkit) to improve depression and pain from de Quervain's tenosynovitis. The investigators hypothesize that both the Decision Aid and the Toolkit will be feasible, and that the Toolkit will improve pain and function compared to usual care.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults (≥18 years) diagnosed with de Quervain's tenosynovitis * English fluency and literacy * Ability to give informed consent Exclusion Criteria: * Inability or unwillingness to participate in decision aid (DA) and/or Toolkit-depression * Major medical comorbidity expected to worsen in the next 6 months * Comorbid chronic pain condition * Antidepressant medications changes in the past 6 months * Severe and untreated mental health conditions or active substance dependence * Secondary gains such as litigations or worker compensation procedures that may interfere with patients' motivation for treatment * No online device available to use the DA and Toolkit-depression

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

QuickDASH score (Disabilities of the Arm Shoulder and Hand)

Timeframe: 6 months

Numerical Pain Rating Scale

Timeframe: 6 months

Trial details

NCT IDNCT04069741

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-02-19

View on ClinicalTrials.gov More De Quervain Disease trials